334 related articles for article (PubMed ID: 22112552)
1. Striatal amyloid plaque density predicts Braak neurofibrillary stage and clinicopathological Alzheimer's disease: implications for amyloid imaging.
Beach TG; Sue LI; Walker DG; Sabbagh MN; Serrano G; Dugger BN; Mariner M; Yantos K; Henry-Watson J; Chiarolanza G; Hidalgo JA; Souders L
J Alzheimers Dis; 2012; 28(4):869-76. PubMed ID: 22112552
[TBL] [Abstract][Full Text] [Related]
2. Neuropathology of Alzheimer's disease: a critical update.
Jellinger KA; Bancher C
J Neural Transm Suppl; 1998; 54():77-95. PubMed ID: 9850917
[TBL] [Abstract][Full Text] [Related]
3. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
[TBL] [Abstract][Full Text] [Related]
5. Thal Amyloid Stages Do Not Significantly Impact the Correlation Between Neuropathological Change and Cognition in the Alzheimer Disease Continuum.
Serrano-Pozo A; Qian J; Muzikansky A; Monsell SE; Montine TJ; Frosch MP; Betensky RA; Hyman BT
J Neuropathol Exp Neurol; 2016 Jun; 75(6):516-26. PubMed ID: 27105663
[TBL] [Abstract][Full Text] [Related]
6. Clinico-Neuropathological Findings in the Oldest Old from the Georgia Centenarian Study.
Tanprasertsuk J; Johnson EJ; Johnson MA; Poon LW; Nelson PT; Davey A; Martin P; Barbey AK; Barger K; Wang XD; Scott TM
J Alzheimers Dis; 2019; 70(1):35-49. PubMed ID: 31177211
[TBL] [Abstract][Full Text] [Related]
7. Extracranial carotid atherosclerosis is associated with increased neurofibrillary tangle accumulation.
Arias JC; Edwards M; Vitali F; Beach TG; Serrano GE; Weinkauf CC
J Vasc Surg; 2022 Jan; 75(1):223-228. PubMed ID: 34478810
[TBL] [Abstract][Full Text] [Related]
8. [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging.
Marquié M; Siao Tick Chong M; Antón-Fernández A; Verwer EE; Sáez-Calveras N; Meltzer AC; Ramanan P; Amaral AC; Gonzalez J; Normandin MD; Frosch MP; Gómez-Isla T
Acta Neuropathol; 2017 Oct; 134(4):619-628. PubMed ID: 28612291
[TBL] [Abstract][Full Text] [Related]
9. Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia.
Janocko NJ; Brodersen KA; Soto-Ortolaza AI; Ross OA; Liesinger AM; Duara R; Graff-Radford NR; Dickson DW; Murray ME
Acta Neuropathol; 2012 Nov; 124(5):681-92. PubMed ID: 22968369
[TBL] [Abstract][Full Text] [Related]
10. Brains with medial temporal lobe neurofibrillary tangles but no neuritic amyloid plaques are a diagnostic dilemma but may have pathogenetic aspects distinct from Alzheimer disease.
Nelson PT; Abner EL; Schmitt FA; Kryscio RJ; Jicha GA; Santacruz K; Smith CD; Patel E; Markesbery WR
J Neuropathol Exp Neurol; 2009 Jul; 68(7):774-84. PubMed ID: 19535994
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of neurofibrillary pathology in a general population to reappraise neuropathological criteria for senile dementia of the neurofibrillary tangle type (tangle-only dementia): the Hisayama Study.
Noda K; Sasaki K; Fujimi K; Wakisaka Y; Tanizaki Y; Wakugawa Y; Kiyohara Y; Iida M; Aizawa H; Iwaki T
Neuropathology; 2006 Dec; 26(6):508-18. PubMed ID: 17203586
[TBL] [Abstract][Full Text] [Related]
12. Pathology of clinical and preclinical Alzheimer's disease.
Thal DR; von Arnim C; Griffin WS; Yamaguchi H; Mrak RE; Attems J; Upadhaya AR
Eur Arch Psychiatry Clin Neurosci; 2013 Nov; 263 Suppl 2():S137-45. PubMed ID: 24077890
[TBL] [Abstract][Full Text] [Related]
13. The histopathological staging of tau, but not amyloid, corresponds to antemortem cognitive status, dementia stage, functional abilities and neuropsychiatric symptoms.
Malpas CB; Sharmin S; Kalincik T
Int J Neurosci; 2021 Aug; 131(8):800-809. PubMed ID: 32303140
[TBL] [Abstract][Full Text] [Related]
14. Braak staging, plaque pathology, and APOE status in elderly persons without cognitive impairment.
Mufson EJ; Malek-Ahmadi M; Perez SE; Chen K
Neurobiol Aging; 2016 Jan; 37():147-153. PubMed ID: 26686670
[TBL] [Abstract][Full Text] [Related]
15. Presence of Striatal Amyloid Plaques in Parkinson's Disease Dementia Predicts Concomitant Alzheimer's Disease: Usefulness for Amyloid Imaging.
Dugger BN; Serrano GE; Sue LI; Walker DG; Adler CH; Shill HA; Sabbagh MN; Caviness JN; Hidalgo J; Saxon-Labelle M; Chiarolanza G; Mariner M; Henry-Watson J; Beach TG;
J Parkinsons Dis; 2012 Jan; 2(1):57-65. PubMed ID: 22924088
[TBL] [Abstract][Full Text] [Related]
16. Detection of Striatal Amyloid Plaques with [18F]flutemetamol: Validation with Postmortem Histopathology.
Beach TG; Thal DR; Zanette M; Smith A; Buckley C
J Alzheimers Dis; 2016 Mar; 52(3):863-73. PubMed ID: 27031469
[TBL] [Abstract][Full Text] [Related]
17. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease.
Newell KL; Hyman BT; Growdon JH; Hedley-Whyte ET
J Neuropathol Exp Neurol; 1999 Nov; 58(11):1147-55. PubMed ID: 10560657
[TBL] [Abstract][Full Text] [Related]
18. Artificial intelligence-derived neurofibrillary tangle burden is associated with antemortem cognitive impairment.
Marx GA; Koenigsberg DG; McKenzie AT; Kauffman J; Hanson RW; Whitney K; Signaevsky M; Prastawa M; Iida MA; White CL; Walker JM; Richardson TE; Koll J; Fernandez G; Zeineh J; Cordon-Cardo C; Crary JF; Farrell K;
Acta Neuropathol Commun; 2022 Oct; 10(1):157. PubMed ID: 36316708
[TBL] [Abstract][Full Text] [Related]
19. Sex-specific modulation of amyloid-β on tau phosphorylation underlies faster tangle accumulation in females.
Wang YT; Therriault J; Servaes S; Tissot C; Rahmouni N; Macedo AC; Fernandez-Arias J; Mathotaarachchi SS; Benedet AL; Stevenson J; Ashton NJ; Lussier FZ; Pascoal TA; Zetterberg H; Rajah MN; Blennow K; Gauthier S; Rosa-Neto P;
Brain; 2024 Apr; 147(4):1497-1510. PubMed ID: 37988283
[TBL] [Abstract][Full Text] [Related]
20. Progression of neurofibrillary changes and PHF-tau in end-stage Alzheimer's disease is different from plaque and cortical microglial pathology.
Thal DR; Arendt T; Waldmann G; Holzer M; Zedlick D; Rüb U; Schober R
Neurobiol Aging; 1998; 19(6):517-25. PubMed ID: 10192210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
